These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32698050)

  • 1. This is your teen brain on drugs: In search of biological factors unique to dependence toxicity in adolescence.
    Kwan LY; Eaton DL; Andersen SL; Dow-Edwards D; Levin ED; Talpos J; Vorhees CV; Li AA
    Neurotoxicol Teratol; 2020; 81():106916. PubMed ID: 32698050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adolescent alcohol exposure: Are there separable vulnerable periods within adolescence?
    Spear LP
    Physiol Behav; 2015 Sep; 148():122-30. PubMed ID: 25624108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique, long-term effects of nicotine on adolescent brain.
    Leslie FM
    Pharmacol Biochem Behav; 2020 Oct; 197():173010. PubMed ID: 32738256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term cognitive consequences of adolescent exposure to recreational drugs of abuse.
    Mooney-Leber SM; Gould TJ
    Learn Mem; 2018 Sep; 25(9):481-491. PubMed ID: 30115770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescence versus adulthood: Differences in basal mesolimbic and nigrostriatal dopamine transmission and response to drugs of abuse.
    Corongiu S; Dessì C; Cadoni C
    Addict Biol; 2020 Jan; 25(1):e12721. PubMed ID: 30779271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and genetic factors underlying co-use of nicotine and alcohol or other drugs of abuse.
    Cross SJ; Lotfipour S; Leslie FM
    Am J Drug Alcohol Abuse; 2017 Mar; 43(2):171-185. PubMed ID: 27532746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and neuronal mechanisms underlying the effects of adolescent nicotine exposure on anxiety and mood disorders.
    Laviolette SR
    Neuropharmacology; 2021 Feb; 184():108411. PubMed ID: 33245960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model.
    Adriani W; Laviola G
    Behav Pharmacol; 2004 Sep; 15(5-6):341-52. PubMed ID: 15343057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peculiar vulnerability to nicotine oral self-administration in mice during early adolescence.
    Adriani W; Macrì S; Pacifici R; Laviola G
    Neuropsychopharmacology; 2002 Aug; 27(2):212-24. PubMed ID: 12093595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine and the adolescent brain.
    Yuan M; Cross SJ; Loughlin SE; Leslie FM
    J Physiol; 2015 Aug; 593(16):3397-412. PubMed ID: 26018031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced nicotine reward in adulthood after exposure to nicotine during early adolescence in mice.
    Kota D; Robinson SE; Imad Damaj M
    Biochem Pharmacol; 2009 Oct; 78(7):873-9. PubMed ID: 19576867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine Gateway Effects on Adolescent Substance Use.
    Ren M; Lotfipour S
    West J Emerg Med; 2019 Aug; 20(5):696-709. PubMed ID: 31539325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescent neurodevelopment and substance use: Receptor expression and behavioral consequences.
    Thorpe HHA; Hamidullah S; Jenkins BW; Khokhar JY
    Pharmacol Ther; 2020 Feb; 206():107431. PubMed ID: 31706976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescent Cannabinoid and Nicotine Exposure Differentially Alters Adult Nicotine Self-Administration in Males and Females.
    Dukes AJ; Fowler JP; Lallai V; Pushkin AN; Fowler CD
    Nicotine Tob Res; 2020 Jul; 22(8):1364-1373. PubMed ID: 32396625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal nicotine or cocaine exposure: which one is worse?
    Slotkin TA
    J Pharmacol Exp Ther; 1998 Jun; 285(3):931-45. PubMed ID: 9618392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 20-year outcomes in adolescents who self-harm: a population-based cohort study.
    Borschmann R; Becker D; Coffey C; Spry E; Moreno-Betancur M; Moran P; Patton GC
    Lancet Child Adolesc Health; 2017 Nov; 1(3):195-202. PubMed ID: 30169168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence.
    Kendler KS; Myers J; Prescott CA
    Arch Gen Psychiatry; 2007 Nov; 64(11):1313-20. PubMed ID: 17984400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls].
    Dorard G; Bungener C; Phan O; Edel Y; Corcos M; Berthoz S
    Encephale; 2018 Feb; 44(1):2-8. PubMed ID: 27637871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of genetic background in the effects of adolescent nicotine exposure on mesolimbic dopamine transmission.
    Cadoni C; De Felice M; Corongiu S; Dessì C; Espa E; Melis M; Fenu S
    Addict Biol; 2020 Sep; 25(5):e12803. PubMed ID: 31342609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.